Kunkun Han

778 total citations
24 papers, 630 citations indexed

About

Kunkun Han is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Kunkun Han has authored 24 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Kunkun Han's work include PI3K/AKT/mTOR signaling in cancer (8 papers), Ubiquitin and proteasome pathways (7 papers) and Genomics and Chromatin Dynamics (3 papers). Kunkun Han is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (8 papers), Ubiquitin and proteasome pathways (7 papers) and Genomics and Chromatin Dynamics (3 papers). Kunkun Han collaborates with scholars based in China, Japan and Italy. Kunkun Han's co-authors include Xinliang Mao, Biyin Cao, Zubin Zhang, Xin Xu, Yili Yang, Yuanying Zeng, Xin Xu, Xiaowen Tang, Ximao Cui and Xiaodan Hou and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and International Journal of Cancer.

In The Last Decade

Kunkun Han

21 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kunkun Han China 18 458 205 90 86 80 24 630
Xiaoying Lan China 15 461 1.0× 227 1.1× 77 0.9× 95 1.1× 34 0.4× 20 699
Ravi Anchoori United States 16 541 1.2× 209 1.0× 63 0.7× 40 0.5× 44 0.6× 26 788
Sarah T. Diepstraten Australia 10 439 1.0× 159 0.8× 102 1.1× 60 0.7× 49 0.6× 18 651
Michał Kuliński Qatar 16 415 0.9× 134 0.7× 167 1.9× 34 0.4× 53 0.7× 19 624
Silke Radetzki Germany 15 517 1.1× 232 1.1× 99 1.1× 26 0.3× 66 0.8× 25 756
Xavier Billot Canada 7 463 1.0× 152 0.7× 55 0.6× 57 0.7× 55 0.7× 10 769
Clara Lemos Netherlands 9 451 1.0× 297 1.4× 39 0.4× 197 2.3× 41 0.5× 10 698
Hugo Seca Portugal 12 375 0.8× 136 0.7× 198 2.2× 131 1.5× 43 0.5× 17 565
Junmei Hou China 5 302 0.7× 109 0.5× 95 1.1× 39 0.5× 46 0.6× 5 502
Matthew Labenski United States 12 405 0.9× 166 0.8× 37 0.4× 50 0.6× 96 1.2× 20 701

Countries citing papers authored by Kunkun Han

Since Specialization
Citations

This map shows the geographic impact of Kunkun Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kunkun Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kunkun Han more than expected).

Fields of papers citing papers by Kunkun Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kunkun Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kunkun Han. The network helps show where Kunkun Han may publish in the future.

Co-authorship network of co-authors of Kunkun Han

This figure shows the co-authorship network connecting the top 25 collaborators of Kunkun Han. A scholar is included among the top collaborators of Kunkun Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kunkun Han. Kunkun Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Wen‐Yue, Han Wang, Xin Xu, et al.. (2025). Natural compound rosmarinic acid displays anti-tumor activity in colorectal cancer cells by suppressing nuclear factor-kappa B signaling. World Journal of Clinical Oncology. 16(5). 105341–105341. 3 indexed citations
3.
4.
Zhong, Liqiang, Xing Fan, Kunkun Han, Wenhua Chen, & Ping Qian. (2022). A degradation model for separable electrical contacts based on the failure caused by surface oxide film. Microelectronics Reliability. 139. 114832–114832. 5 indexed citations
5.
Xu, Xin, Aiwen Huang, Ximao Cui, et al.. (2019). Ubiquitin specific peptidase 5 regulates colorectal cancer cell growth by stabilizing Tu translation elongation factor. Theranostics. 9(14). 4208–4220. 59 indexed citations
6.
Xu, Xin, Ximao Cui, Kunkun Han, et al.. (2019). Inhibition of Ubiquitin Specific Protease 1 Sensitizes Colorectal Cancer Cells to DNA-Damaging Chemotherapeutics. Frontiers in Oncology. 9. 1406–1406. 44 indexed citations
7.
Ren, Ying, Xin Xu, Chenyu Mao, et al.. (2019). RNF6 promotes myeloma cell proliferation and survival by inducing glucocorticoid receptor polyubiquitination. Acta Pharmacologica Sinica. 41(3). 394–403. 25 indexed citations
8.
Zeng, Yuanying, Xin Xu, Siyu Wang, et al.. (2017). Ring finger protein 6 promotes breast cancer cell proliferation by stabilizing estrogen receptor alpha. Oncotarget. 8(12). 20103–20112. 21 indexed citations
9.
Xu, Xin, Kunkun Han, Xiaowen Tang, et al.. (2016). The Ring Finger Protein RNF6 Induces Leukemia Cell Proliferation as a Direct Target of Pre-B-cell Leukemia Homeobox 1. Journal of Biological Chemistry. 291(18). 9617–9628. 51 indexed citations
10.
Zhang, Zubin, Jingyu Zhu, Yujia Xu, et al.. (2016). A novel small molecule agent displays potent anti-myeloma activity by inhibiting the JAK2-STAT3 signaling pathway. Oncotarget. 7(8). 9296–9308. 27 indexed citations
11.
Han, Kunkun, Xin Xu, Guodong Chen, et al.. (2015). SC06, a novel small molecule compound, displays preclinical activity against multiple myeloma by disrupting the mTOR signaling pathway. Scientific Reports. 5(1). 12809–12809. 19 indexed citations
12.
Chen, Guodong, Xin Xu, Jiefei Tong, et al.. (2014). Ubiquitination of the transcription factor c-MAF is mediated by multiple lysine residues. The International Journal of Biochemistry & Cell Biology. 57. 157–166. 28 indexed citations
13.
Han, Kunkun, Xin Xu, Guodong Chen, et al.. (2014). Identification of a promising PI3K inhibitor for the treatment of multiple myeloma through the structural optimization. Journal of Hematology & Oncology. 7(1). 9–9. 47 indexed citations
14.
Shi, Min, Xiumin Zhou, Zubin Zhang, et al.. (2014). A novel PI3K inhibitor displays potent preclinical activity against an androgen-independent and PTEN-deficient prostate cancer model established from the cell line PC3. Toxicology Letters. 228(3). 133–139. 17 indexed citations
15.
Zhu, Jingyu, Man Wang, Yang Yu, et al.. (2014). A novel PI3K inhibitor PIK-C98 displays potent preclinical activity against multiple myeloma. Oncotarget. 6(1). 185–195. 18 indexed citations
16.
Xu, Xin, Jieyu Zhang, Kunkun Han, et al.. (2014). Natural Pesticide Dihydrorotenone Arrests Human Plasma Cancer Cells at the G0/G1 Phase of the Cell Cycle. Journal of Biochemical and Molecular Toxicology. 28(5). 232–238. 19 indexed citations
17.
Cao, Biyin, Jie Li, Xiumin Zhou, et al.. (2014). Clioquinol induces pro-death autophagy in leukemia and myeloma cells by disrupting the mTOR signaling pathway. Scientific Reports. 4(1). 61 indexed citations
18.
Cao, Biyin, Jie Li, Jingyu Zhu, et al.. (2013). The Antiparasitic Clioquinol Induces Apoptosis in Leukemia and Myeloma Cells by Inhibiting Histone Deacetylase Activity. Journal of Biological Chemistry. 288(47). 34181–34189. 44 indexed citations
19.
Shi, Min, Tingting Kong, Chengmei Zhang, et al.. (2013). Preparation of S14161 and its analogues and the discovery of 6-bromo-8-ethoxy-3-nitro-2H-chromene as a more potent antitumor agent in vitro. Bioorganic & Medicinal Chemistry Letters. 23(11). 3314–3319. 43 indexed citations
20.
Ling, Chunhua, Guodong Chen, Zubin Zhang, et al.. (2012). A deuterated analog of dasatinib disrupts cell cycle progression and displays anti‐non‐small cell lung cancer activity in vitro and in vivo. International Journal of Cancer. 131(10). 2411–2419. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoying Lan Breakdown of academic impact, for papers by Ravi Anchoori Breakdown of academic impact, for papers by Sarah T. Diepstraten Breakdown of academic impact, for papers by Michał Kuliński Breakdown of academic impact, for papers by Silke Radetzki Breakdown of academic impact, for papers by Xavier Billot Breakdown of academic impact, for papers by Clara Lemos Breakdown of academic impact, for papers by Hugo Seca Breakdown of academic impact, for papers by Junmei Hou Breakdown of academic impact, for papers by Matthew Labenski
Rankless by CCL
2026